| A review of responsive MRI contrast agents: 2005–2014 DV Hingorani, AS Bernstein, MD Pagel Contrast media & molecular imaging 10 (4), 245-265, 2015 | 245 | 2015 |
| A catalyCEST MRI contrast agent that detects the enzyme-catalyzed creation of a covalent bond DV Hingorani, EA Randtke, MD Pagel Journal of the American Chemical Society 135 (17), 6396-6398, 2013 | 75 | 2013 |
| Nerve-targeted probes for fluorescence-guided intraoperative imaging DV Hingorani, MA Whitney, B Friedman, JK Kwon, JL Crisp, Q Xiong, ... | 65 | 2018 |
| Impact of MMP-2 and MMP-9 enzyme activity on wound healing, tumor growth and RACPP cleavage DV Hingorani, CN Lippert, JL Crisp, EN Savariar, JPC Hasselmann, ... PLoS One 13 (9), e0198464, 2018 | 61 | 2018 |
| Cell penetrating peptide functionalized perfluorocarbon nanoemulsions for targeted cell labeling and enhanced fluorine‐19 MRI detection DV Hingorani, F Chapelin, E Stares, SR Adams, H Okada, ET Ahrens Magnetic resonance in medicine 83 (3), 974-987, 2020 | 56 | 2020 |
| Detecting enzyme activities with exogenous MRI contrast agents DV Hingorani, B Yoo, AS Bernstein, MD Pagel Chemistry–A European Journal 20 (32), 9840-9850, 2014 | 56 | 2014 |
| A single diamagnetic catalyCEST MRI contrast agent that detects cathepsin B enzyme activity by using a ratio of two CEST signals DV Hingorani, LA Montano, EA Randtke, YS Lee, J Cárdenas‐Rodríguez, ... Contrast media & molecular imaging 11 (2), 130-138, 2016 | 44 | 2016 |
| Monomethyl auristatin antibody and peptide drug conjugates for trimodal cancer chemo-radio-immunotherapy DV Hingorani, MM Allevato, MF Camargo, J Lesperance, MA Quraishi, ... Nature communications 13 (1), 3869, 2022 | 32 | 2022 |
| Precision chemoradiotherapy for HER2 tumors using antibody conjugates of an auristatin derivative with reduced cell permeability DV Hingorani, MK Doan, MF Camargo, J Aguilera, SM Song, D Pizzo, ... Molecular cancer therapeutics 19 (1), 157-167, 2020 | 26 | 2020 |
| Early detection of squamous cell carcinoma in carcinogen induced oral cancer rodent model by ratiometric activatable cell penetrating peptides DV Hingorani, AJ Lemieux, JR Acevedo, HL Glasgow, S Kedarisetty, ... Oral oncology 71, 156-162, 2017 | 23 | 2017 |
| Redirecting extracellular proteases to molecularly guide radiosensitizing drugs to tumors DV Hingorani, JL Crisp, MK Doan, MF Camargo, MA Quraishi, J Aguilera, ... Biomaterials 248, 120032, 2020 | 22 | 2020 |
| Tumor activated cell penetrating peptides to selectively deliver immune modulatory drugs DV Hingorani, MF Camargo, MA Quraishi, SR Adams, SJ Advani Pharmaceutics 13 (3), 365, 2021 | 15 | 2021 |
| Detection of subclinical arthritis in mice by a thrombin receptor–derived imaging agent B Friedman, MA Whitney, EN Savariar, C Caneda, P Steinbach, Q Xiong, ... Arthritis & Rheumatology 70 (1), 69-79, 2018 | 6 | 2018 |
| Contrast Media Mol DV Hingorani, AS Bernstein, MD Pagel I 10, 245, 2015 | 5 | 2015 |
| Sensing lanthanide metal content in biological tissues with magnetic resonance spectroscopy DV Hingorani, SI Gonzalez, JF Li, MD Pagel Sensors 13 (10), 13732-13743, 2013 | 5 | 2013 |
| Vagal innervation of the esophagus and stomach: Visualized using a novel nerve peptide (NP41) Y Jiang, Q Ngyen, M Whitney, D Hingorani, G Ihn, RK Mittal Gastroenterology 152 (5), S932, 2017 | 3 | 2017 |
| An enzyme-responsive PARACEST MRI contrast agent that “turns on” after catalysis DV Hingorani, MD Pagel Proceedings of the International Society for Magnetic Resonance in Medicine …, 2012 | 2 | 2012 |
| An overview of site-specific methods for achieving antibody drug conjugates with homogenous drug to antibody ratio DV Hingorani Expert Opinion on Biological Therapy 24 (1-2), 31-36, 2024 | 1 | 2024 |
| Tumor Activated Cell Penetrating Peptides to Selectively Deliver Immune Modulatory Drugs. Pharmaceutics 2021, 13, 365 DV Hingorani, MF Camargo, MA Quraishi, SR Adams, SJ Advani s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021 | 1 | 2021 |
| Thrombin receptor-derived imaging agent detects subclinical arthritis in mice B Friedman, M Whitney, E Savariar, C Caneda, P Steinbach, Q Xiong, ... Arthritis Rheumatol, 2017 | 1 | 2017 |